Latest Content

Jessilin Quint, OD, MBA, FAAO, said that integrating AI into your practice can start small.

A large real-world cohort study by Takashi Nishida, MD, PhD et al finds OSA is associated with elevated glaucoma risk.

According to the survey, one in five sufferers reported that dry eye symptoms affect their self-confidence (22%) and emotional wellbeing (20%).

Shareen M. Greenbaum, MD, and Amanda Amberg, OD, recognize comanagement as an opportunity to target dry eye early and use advanced diagnostics and treatments for healthier ocular surfaces.

Neda Gioia, OD, CNS, FMCP, FOWNS, CFMP, details what she finds concerning and surprising in a recent study she conducted with Kaleb Abbott, OD, MS, FAAO, FOWNS.

In this podcast, retina specialist John Kitchens, MD, has a conversation with a patient about the choice he made for anti-VEGF therapy to reduce his treatment burden, then discusses recent clinical trial data on therapeutic options with extended treatment intervals.

Kaleb Abbott, OD, MS, FAAO, FOWNS, details one of his lectures during AOA's Optometry's Meeting 2026.

Jacqueline Theis, OD, FAAO, gave tips to clinicians on how to critically read studies in order to assess if they are applicable to their everyday practice.

Denise Whittam, OD, said that the Acuvue Oasys lens family holds her go-to lenses for patients for their comfortability.

Choosing the right patients for soft lenses, orthokeratology, and spectacle lenses has long-lasting effects on the vision health of those with myopia.

FDA clears Lumvoa for active and chronic thyroid eye disease, offering rapid proptosis and diplopia gains—plus key safety monitoring tips.

Canto-Sims, OD, discusses how Meta's donation of free AI glasses to blind veterans could close longstanding access gaps in low vision care.

Erin Rueff, OD, PhD, FAAO, provides an introduction to Johnson & Johnson's versatile contact lens family.